MBX
MBX
US55287L1017
MBX Biosciences, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue -- --
--
Cost of Revenue -- --
--
Gross Profit -- --
--
98.055.000 68.194.000
43.8%
Operating Income -98.055.000 -68.194.000
43.8%
Pretax Income -86.971.000 -61.922.000
40.5%
Net Income Common Stockholders -86.971.000 -61.922.000
40.5%
-- --
--
-- --
--
ende